Dolutegravir Prices

Dolutegravir Prices March 2023

In Q1 2024, market pricing in India was driven by increased demand, positive market sentiment, and rising oil prices. Despite the obstacles, the market recovered with increased trade activity and regular output rates. Besides this, supply levels remained low, prompting merchants to sell inventory at high prices. This resulted in higher pricing, reflecting customer confidence and purchase activity. Aside from this, the festival season also led to price hikes. Moreover, quarter-end destocking actions had a further influence on pricing, resulting in a final price settlement of 266,235 USD/ MT, with a minor quarterly decline.

Dolutegravir Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Dolutegravir Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of dolutegravir pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of dolutegravir at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of dolutegravir price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing dolutegravir price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Dolutegravir Market Analysis

The global dolutegravir market size reached US$ 5.2 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 8.1 Billion, at a projected CAGR of 5.00% during 2023-2032.

• The market has experienced robust growth, driven by the rising prevalence of human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) worldwide, fueling the demand for effective antiretroviral therapies for viral suppression and improved patient outcomes.
• In confluence with this, the escalating awareness about the benefits of early HIV diagnosis and treatment has led to higher adoption rates of dolutegravir-based regimens, creating a positive outlook for market expansion.
• Moreover, the implementation of favorable government initiatives and funding support aimed at combating the HIV/AIDS epidemic have facilitated greater access to this medicine in developing countries, thereby bolstering the market growth.
• The emergence of drug-resistant HIV strains necessitating the development and adoption of novel antiretroviral drugs like this, which exhibit a higher genetic barrier to resistance is acting as another significant growth-inducing factor.
• Concurrent with this, significant advancements in pharmaceutical research and development (R&D) have resulted in the introduction of the formulation of this drug with improved efficacy, safety, and tolerability profiles, further strengthening the expanding market.
• Strategic collaborations and partnerships between pharmaceutical companies and healthcare organizations facilitating the development, production, and distribution of this medicine are positively impacting the market growth.
• Moreover, the growing demand for single-tablet regimens incorporating this pharmaceutical API has simplified treatment regimens and improved patient adherence, thereby aiding in market expansion.
• In line with this, the increasing focus on healthcare infrastructure development and capacity building in emerging economies has improved access to dolutegravir-based therapies, influencing the market growth.
• Furthermore, the introduction of favorable reimbursement policies and insurance coverage for HIV/AIDS treatment have incentivized patient compliance and contributed to the uptake of this medicine in both developed and developing markets, thereby fostering market expansion.
• Apart from this, the growing emphasis on HIV prevention strategies such as pre-exposure prophylaxis (PrEP) spurring the demand for dolutegravir-based regimens for use in HIV prevention programs is presenting lucrative opportunities for market expansion.

Dolutegravir News

The report covers the latest developments, updates, and trends impacting the global dolutegravir market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in dolutegravir production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the dolutegravir price trend.

Latest developments in the dolutegravir industry:

• In September 2023, ViiV Healthcare received tentative approval from the US FDA for a dispersible tablet formulation of abacavir, dolutegravir, and lamivudine for HIV-1 treatment in pediatric patients aged 3 months and above.
• In April 2022, Qilu Pharmaceuticals approved its "dotegravir sodium tablet" application for listing, marking the first time a Chinese company has declared a generic drug for Dolutegravir, an anti-AIDS drug developed by GlaxoSmithKline/ViiV.

Product Description

Dolutegravir is an antiretroviral medicine used in conjunction with other treatments to treat HIV infection in adults and adolescents over the age of 12 who weigh at least 40 kg. It functions as an integrase inhibitor, preventing the virus from using the integrase enzyme to replicate itself within the body.

Owing to its high genetic resistance barrier, this drug functions as an integral part of HIV therapy regimens, particularly for patients who have not responded to previous treatment attempts. This drug is sold in tablet form for oral administration, with dose regimens dependent on the patient's age, weight, renal function, and current medicines. It is only available with a prescription, which should only be written by a medical professional skilled in treating HIV infection.

With its strong viral suppression, resistance to side effects, and safety features, this medication represents a major breakthrough in the treatment of HIV/AIDS, improving the prognosis and quality of life for those who suffer from this chronic illness.

Regional Coverage

The report provides a detailed analysis of the dolutegravir market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the dolutegravir price trend.

Global Dolutegravir Price

The report offers a holistic view of the global dolutegravir pricing trends in the form of dolutegravir price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of dolutegravir but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed dolutegravir demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Dolutegravir Price

During the first quarter, there were notable price swings in the European market, which were initially fueled by robust product demand. Prices did, however, decline as a result of excessive hoarding, weak demand in downstream industries, and diminished import opportunities. March saw lower production expenses due to lower freight charges and lower raw material prices. Unimproved purchase levels from downstream sectors, however, raised worries.

This analysis can be extended to include detailed dolutegravir price information for a comprehensive list of countries.

North America Dolutegravir Price

The market in North America experienced fluctuation in Q1 2024, with prices rising as a result of higher demand. However, prices went up as a result of lower freight expenses and higher manufacturing costs. Prices fell in March as a consequence of excessive hoarding, sluggish demand in the downstream sectors, and dimmed import expectations. Because of the excess, exporting areas had to reduce their prices, underscoring the significance of maintaining competitiveness in an area with high import volumes.

Specific dolutegravir historical data within the United States and Canada can also be provided.

Middle East and Africa Dolutegravir Price

The report explores the dolutegravir pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on dolutegravir prices for countries can also be provided.

Asia Pacific Dolutegravir Price

The Asia Pacific market saw a spike in demand in Q1 2024, mostly due to foreign trade orders and robust downstream sector demand. Rising oil costs, however, presented difficulties and had an impact on profitability. In spite of this, the market saw improvement because of increased trade activity and steady production rates. Prices rose as a result of the shortage as supply levels remained low. The Festival Season and other seasonal circumstances also led to price increases.

This dolutegravir price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Dolutegravir Price

The analysis of dolutegravir prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of dolutegravir pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting dolutegravir price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The dolutegravir price charts ensure our clients remain at the forefront of the industry.